RANI

1.47

3.92% -0.06

Dopo l'orario di chiusura: 1.51 0.04 +2.72%

Rani Therapeutics Holdings Inc (RANI)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$1.53

Aprire:

$1.54

Volume 24 ore:

462.13K

Relative Volume:

0.49

Capitalizzazione di mercato:

$48.63M

Reddito:

$3.04M

Utile/perdita netta:

$-33.97M

Rapporto P/E:

-1.1053

EPS:

-1.33

Flusso di cassa netto:

$-52.47M

1 W Prestazione:

-3.29%

1M Prestazione:

+8.09%

6M Prestazione:

-50.34%

1 anno Prestazione:

-60.16%

Intervallo 1D:

$1.4101

$1.54

Intervallo di 1 settimana:

$1.4101

$1.58

Portata 52W:

$1.24

$8.75

Rani Therapeutics Holdings Inc Stock (RANI) Company Profile

Nome

Rani Therapeutics Holdings Inc

Settore

Healthcare (1189)

Industria

Biotechnology (682)

Telefono

(408) 457-3700

Indirizzo

2051 RINGWOOD AVENUE, SAN JOSE

Dipendente

140

Cinguettio

Prossima data di guadagno

2024-11-08

Ultimi documenti SEC

RANI's Discussions on Twitter

Confronta RANI con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
RANI Rani Therapeutics Holdings Inc	1.47	48.63M	3.04M	-33.97M	-52.47M	-1.33
VRTX Vertex Pharmaceuticals Inc	483.31	124.35B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	684.87	75.07B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	622.61	37.96B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	243.53	31.79B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	111.56	27.34B	3.30B	-501.07M	1.03B	-2.1146

Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-08-02	Iniziato	Oppenheimer	Outperform
2024-06-14	Iniziato	Maxim Group	Buy
2024-06-13	Iniziato	Rodman & Renshaw	Buy
2023-04-17	Ripresa	BTIG Research	Buy
2022-10-11	Iniziato	UBS	Buy
2022-07-27	Iniziato	H.C. Wainwright	Buy
2022-06-13	Iniziato	Wedbush	Outperform

Mostra tutto

Rani Therapeutics Holdings Inc Borsa (RANI) Ultime notizie

Mar 01, 2025

Rani Therapeutics’ (RANI) Buy Rating Reiterated at Canaccord Genuity Group - Defense World

Mar 01, 2025

Feb 27, 2025

Canaccord Genuity Group Reiterates Buy Rating for Rani Therapeutics (NASDAQ:RANI) - MarketBeat

Feb 27, 2025

Feb 15, 2025

Power to the People: How Individual Investors Shape Rani Therapeutics - Smartphone Magazine

Feb 15, 2025

Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) largest shareholders are individual investors who were rewarded as market cap surged US$11m last week - Yahoo Finance

Feb 15, 2025

Feb 14, 2025

RANI Shares Experience Surge in Value - Knox Daily

Feb 14, 2025

Janney Montgomery Scott LLC Buys New Position in Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) - Defense World

Feb 14, 2025

Feb 12, 2025

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Given Consensus Rating of "Buy" by Analysts - MarketBeat

Feb 12, 2025

Feb 11, 2025

Rani Therapeutics (NASDAQ:RANI) Given Buy Rating at HC Wainwright - MarketBeat

Feb 11, 2025

Analysts Set Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Target Price at $12.33 - Defense World

Feb 11, 2025

Feb 10, 2025

Analyzing PSQ Holdings Inc (PSQH) After Recent Trading Activity - Knox Daily

Feb 10, 2025

Rani Therapeutics’ (RANI) Buy Rating Reiterated at HC Wainwright - Defense World

Feb 10, 2025

These 5 Health Care Stocks Saw The Sharpest Retail Interest Jump Last Week - Asianet Newsable

Feb 10, 2025

Feb 08, 2025

Rani Therapeutics (NASDAQ:RANI) Shares Up 0.7%Time to Buy? - MarketBeat

Feb 08, 2025

Rani Therapeutics (NASDAQ:RANI) Receives “Buy” Rating from HC Wainwright - Armenian Reporter

Feb 08, 2025

Feb 07, 2025

Was there any good news for Rani Therapeutics Holdings Inc (RANI) stock in the last session? - US Post News

Feb 07, 2025

Is Rani Therapeutics Holdings (NASDAQ:RANI) Using Too Much Debt? - Simply Wall St

Feb 07, 2025

Feb 06, 2025

Market cap of Tantech Holdings Ltd [TANH] reaches 1.11M – now what? - The DBT News

Feb 06, 2025